Expression of receptor activator of NFkB (RANK) drives stemness and resistance to therapy in ER+HER2- breast cancer

Overview of attention for article published in Oncotarget, May 2020

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,815 followers.

Expression of receptor activator of NFkB (RANK) drives stemness and resistance to therapy in ... https://t.co/96TXzmNaqr

New article: Expression of receptor activator of NFkB (RANK) drives stemness and resistance to therapy in ER+HER2- breast cancer. https://t.co/bbOJ4klecR #breastcancer #oncology https://t.co/Bp3Euo6jXI